Peripheral T-Cell Lymphoma in Children and Adolescents: Role of Bone Marrow Transplantation

References

• Weis J. W., Winter M. W., Phyliky R. L., et al. Peripheral T-cell lymphomas: histologic, immunohistologic, and clinical characterization. Mayo Clin. Proc 1986; 61: 411–426
   PubMed Web of Science ®Google Scholar
• Rudders R. A., De Lellis R. A., Ahl E. T., Jr., et al. Adult non-Hodgkins lymphoma: correlation of cell surface marker phenotype with prognosis, the New Working Formulation, and the Rappaport and Lukes-Collins histomor-phologic schemes. Cancer 1983; 52: 2289–2299
   PubMed Web of Science ®Google Scholar
• Jaffe E. S. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest. 1984; 2: 413–426
   PubMed Web of Science ®Google Scholar
• Armitage J. O., Greer J. P., Levine A. M., et al. Peripheral T-cell lymphoma. Cancer 1989; 63: 158–163
   PubMed Web of Science ®Google Scholar
• Pinkus G. S., O'Hara C. J., Said J. W. Peripheral/post-thymic T-cell lymphomas: a spectrum of disease. Clinical, pathologic and immunologic features of 78 cases. Cancer 1990; 65: 971–998
   PubMed Web of Science ®Google Scholar
• Greer J. P., York J. C., Cousar J. B., et al. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. J. Clin. Oncol. 1984; 2: 788–798
   PubMed Web of Science ®Google Scholar
• Murphy S. B. Classification, staging and end-results of treatment of childhood non-Hodgkins lymphoma. Dissimilarities from lymphoma in adults. Semin. Oncol. 1980; 7: 332–339
   PubMed Web of Science ®Google Scholar
• Gordon B. G., Weisenburger D. D., Warkentin P. I., et al. Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients. Cancer 1993; 71: 257–263
   PubMed Web of Science ®Google Scholar
• Leake J., Kellie S. J., Pritchard J., et al. Peripheral T-cell lymphoma in childhood. A clinicopathologic study of six cases. Histopathology 1989; 14: 255–268
   PubMed Web of Science ®Google Scholar
• Kadin M. E., Sako D., Berliner N., et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 1986; 68: 1042–1049
   PubMed Web of Science ®Google Scholar
• Bucsky P., Feller A. C., Reiter A., et al. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood-a BFM Study Group report. Klin. Padiatr. 1990; 202: 258–261
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Reichert T. A., Brynes R. K., et al. The phenotypic diversity of peripheral T-cell lymphoma. The South Eastern Cancer Study Group experience. Human Pathol. 1986; 17: 567–574
   PubMed Web of Science ®Google Scholar
• Lennert K., Stein H., Feller A. C., . Morphology, cytochemistry and immunohistology of T-cell lymphomas B and T Cell Tumours: UCLA Symp. Mol. Cell. Biol, E. S. Vitetta, et al. Academic Press, New York 1982; 9–28
   Google Scholar
• Stein H., Mason D. Y., Gerdes J., et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic tissue. Evidence that Reed-Stemberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858
   PubMed Web of Science ®Google Scholar
• Armitage J. O. Bone marrow transplantation in the treatment of patients with lymphoma. Blood 1989; 73: 1749–1758
   PubMed Web of Science ®Google Scholar
• Philip T., Armitage J. O., Spitzer G., et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N. Engl. J. Med. 1987; 316: 1493–1498
   PubMed Web of Science ®Google Scholar
• O'Leary M., Ramsay N. K., Nesbit M. E., et al. Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults. Am. J. Med. 1983; 74: 497–501
   PubMed Web of Science ®Google Scholar
• Bierman P. J., Peterson C., Vose J. M., et al. Autologous bone marrow transplantation (ABMT) for patients with T-cell non-Hodgkin's lymphoma (T-NHL). Proc. Am. Soc. Clin. Oncol. 1989; 8: 225a, Abstract
   Google Scholar
• Vose J. M., Peterson C., Bierman P. J., et al. Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood 1990; 76: 424–431
   PubMed Web of Science ®Google Scholar
• Gordon B. G., Warkentin P. I., Weisenburger D. D., et al. Bone marrow transplantation for peripheral T-cell lymphoma in children and young adults. Blood 1992; 80: 2938–2942
   PubMed Web of Science ®Google Scholar
• Chott A., Augustin I., Wrba F., et al. Peripheral T-cell lymphomas: a clinicopathologic study of 75 cases. Human Pathol. 1990; 21: 1117–1125
   PubMed Web of Science ®Google Scholar
• Kadin M. E. Ki-1-positive anaplastic large cell lymphoma: a clinicopathologic entity?. J. Clin. Oncol. 1991; 9: 533–536
   PubMed Web of Science ®Google Scholar
• Chan J. K. C., Ng C. S., Hui P. K., et al. Anaplastic large cell Ki-1 lymphoma. Delineation of two morphologic types. Histopathologv 1989; 15: 11–34
   PubMed Web of Science ®Google Scholar
• Chott A., Kaserer K., Augustin I., et al. Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am. J. Surg. Pathol. 1990; 14: 439–448
   PubMed Web of Science ®Google Scholar
• Bitter M. A., Franklin W. A., Larson R. A., et al. Morphology in Ki-1(CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am. J. Surg. Pathol. 1990; 14: 305–316
   PubMed Web of Science ®Google Scholar
• Stansfeld A. G., Diebold J., Kapanci Y., et al. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292–293
   PubMed Web of Science ®Google Scholar
• Whitlock J. A., Kinney M. C., Lukens J. N., et al. Childhood Ki-1 lymphomas: clinicopathologic features and outcome. Blood 1991; 78(Suppl. 1)272a, Abstract
   Google Scholar
• Schnitzer B., Roth M. S., Hyder D. M., et al. Ki-1 lymphoma in children. Cancer 1988; 61: 1213–1221
   PubMed Web of Science ®Google Scholar
• Wollman M., Blatt J., Nelson K., et al. Ki-1 lymphomas in childhood: a report of 9 cases from a single institution. Proc. Am. Soc. Clin. Oncol. 1992; 11: 342, Abstract
   Google Scholar
• Oka K., Mori N., Kojima M., et al. Childhood Ki-1 lymphoma. A report of two cases. Arch. Pathol. Lab. Med. 1989; 113: 998–1002, Abstract
   PubMed Web of Science ®Google Scholar
• Kadin M. E., Sposto R, Agnarsson B. A., et al. Ki-1 antigen expression in childhood non-Hodgkin's lymphoma. Blood 1987; 70(Suppl. 1)260a, Abstract
   Google Scholar
• Hutchison R. E., Berard C. W., Shuster J. J., et al. Immunophenotype influences survival in pediatric large cell lymphoma. A Pediatric Oncology Group study (abstract). 5th Int. Conf. Malignant Lymphoma, Lugano, 1993
   Google Scholar
• Horning S. J., Weiss L. M., Crabtree G. S., et al. Clinical and phenotypic diversity of T-cell lymphomas. Blood 1986; 67: 1578–1582
   PubMed Web of Science ®Google Scholar
• Hanson C. A., Brunning R. D., Gajl-Peczalska K. J., et al. Bone marrow manifestations of peripheral T-cell lymphoma. A study of 30 cases. Am. J. Clin. Pathol. 1986; 86: 449–460
   PubMed Web of Science ®Google Scholar
• Brouet J., Rabin C., Gisselbrecht C., et al. Clinical and immunologic study of non-Hodgkin's T-cell lymphomas (cutaneous and lymphoblastic lymphomas excluded). Br. J. Haematol. 1984; 57: 315–327
   PubMed Web of Science ®Google Scholar
• Weisenburger D. D., Linder J., Armitage J. O. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. Hematol. Oncol. 1987; 5: 175–187
   PubMed Web of Science ®Google Scholar
• Grogan T. M., Fiedler K., Rangel C., et al. Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes. Am. J. Clin. Path. 1985; 83: 279–288
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Crabtree G. S., Rouse R. V., et al. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am. J. Pathol. 1985; 118: 316–324
   PubMed Web of Science ®Google Scholar
• Le Beau M. M., Bitter M. A., Larson R. A., et al. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 1989; 3: 866–870
   PubMed Web of Science ®Google Scholar
• Mason D. Y., Bastard C., Rimokh R., et al. CD30-positive large cell lymphomas (‘Ki-1 lymphoma’) are associated with a chromosomal translocation involving 5q35. Br. J. Haematol. 1990; 74: 161–168
   PubMed Web of Science ®Google Scholar
• Vecchi V., Pileri S., Burnelli R., et al. Anaplastic large-cell lymphoma (Ki-1 + /CD30+) in childhood (abstract). 4th Int. Conf. Malignant Lymphoma. Lugano 1990
   Google Scholar
• Coiffier B., Brousse N., Peuchmaur M., et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Ann. Oncol. 1990; 1: 45–50
   PubMed Web of Science ®Google Scholar
• Weisenburger D. D., Harrington D., Linder J., et al. Pathologic features predict clinical outcome in peripheral T-cell lymphoma. Mod. Pathol. 1989; 2: 104A, Abstract
   Google Scholar
• Armitage J. O., Vose J. M., Linder J., et al. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma. J. Clin. Oncol. 1989; 7: 1783–1790
   PubMed Web of Science ®Google Scholar
• Kwak L. W., Wilson M., Weiss L. M., et al. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience. J. Clin. Oncol. 1991; 9: 1426–1431
   PubMed Web of Science ®Google Scholar
• Horning S. J., Doggett R. S., Warnke R. A., et al. Clinical relevance of immunologic phenotype in diffuse large cell lymphoma. Blood 1984; 63: 1209–1215
   PubMed Web of Science ®Google Scholar
• Offit K., Ladanyi M., Gangi M. D., et al. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 1990; 4: 625–630
   PubMed Web of Science ®Google Scholar
• Kadin M. E., Anderson J. A., Chilcote R. R., et al. Lack of prognostic significance of Ki-1 (CD30) positivity in disseminated pediatric large cell lymphoma. Blood 1991; 78: 121a, Abstract
   Google Scholar
• Chakravarti V., Kamani N. R., Bayever E., et al. Bone marrow transplantation for childhood Ki-1 lymphoma. J. Clin. Oncol. 1990; 8: 657–660
   PubMed Web of Science ®Google Scholar
• Bateman J. C. Chemotherapy of solid tumors with triethylene thiophosphoramide. N. Engl. J. Med. 1955; 252: 879–887
   PubMed Web of Science ®Google Scholar
• Brindley C. O., Slavin L. G., Potee K. G., et al. Further comparative trial of triethylene thiophosphoramide and mechlorethamine in patients with melanoma and Hodgkin's disease. J. Chron. Dis. 1964; 17: 19–30
   PubMedGoogle Scholar
• Olson K. B. The treatment of advanced cancer with triethylenethiophosphoramide. Ann. NY Acad. Sci. 1958; 68: 1018–1023
   PubMed Web of Science ®Google Scholar
• Wright J. C., Golomb F. M., Gumport S. L. Summary of results with triethylene thiophosphoramide. Ann. NY Acad. Sci. 1958; 68: 937–965
   PubMed Web of Science ®Google Scholar
• Tullis J. L. Triethylenephosphoramide in the treatment of disseminated melanoma. J. Am. Med. Assoc 1958; 166: 37–41
   PubMed Web of Science ®Google Scholar
• Edwards M. S., Levin V. A., Seager M. L., et al. Phase II evaluation of thioTEPA for treatment of central nervous system tumors. Cancer Treat. Rep. 1979; 8: 1419
   Google Scholar
• Herzig R. H., Brown R. A., Fay J. W., et al. Phase I and II studies of high dose N,N′,N″-triethylene thiophosphoramide and autologous marrow transplantation in patients with refractory malignancies. Cancer Ther. Control 1990; 1: 141–153
   Google Scholar
• Strandjord S. E., Saarinen U., Warkentin P. I., et al. High dose N,N′,N″-triethylenethiophosphoramide in pediatric phase I/II autologous bone marrow transplantation studies. Exp. Hematol. 1988; 16: 503a, Abstract
   Web of Science ®Google Scholar
• Bitran J. D., Williams S. F., Moormeier J., et al. High dose combination chemotherapy with thiotepa and autologous hematopoietic stem cell reinfusion in the treatment of patients with relapsed refractory lymphomas. Semin. Oncol. 1990; 17(Suppl. 3)39–42
   PubMedGoogle Scholar
• Teicher B. A., Cucchi C. A., Lee J. B., et al. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Cancer Res. 1986; 46: 4379–4383
   PubMed Web of Science ®Google Scholar
• Warkentin P. I., Brochstein J. A., Strandjord S. E., et al. High dose therapy followed by autologous stem cell rescue for recurrent Wilms' tumor. J. Clin. Oncol. 1993; 11: 414, Abstract
   Google Scholar
• Murphy S. B. Prognostic features and obstacles to cure of childhood non-Hodgkin's lymphoma. Semin. Oncol. 1977; 4: 265–271
   PubMed Web of Science ®Google Scholar
• Berkowitz R. J., Hughes C., Rudnick M., et al. Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients. Am. J. Pediatr. Hematol. Oncol. 1985; 7: 82–86
   PubMedGoogle Scholar